Home Century Therapeutics

Century Therapeutics

In operation
Post-IPO Round
Developer of Transformative Allogeneic Cell Therapies
Basic
Enterprise Profile

Basic Information

Century Therapeutics is an innovative biotechnology company dedicated to developing transformative allogeneic cell therapies and creating treatments for solid tumors and hematologic malignancies. Leveraging its integrated cell therapy platform, the company develops transformative allogeneic cell therapies with the potential to overcome many inherent challenges in cell therapy. Century’s genetically engineered, iPSC-derived immune effector cell products aim to harness the power of adult stem cells to specifically target blood cancers and solid tumors, offering patients an unparalleled opportunity to advance cancer treatment.
Century Therapeutics, Inc.
Philadelphia,Pennsylvania,United States of America
15~50 people
January 01, 2018
--

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy Production of Genetically Engineered Drugs
Technology
Gene Technology Immunological Techniques Cell Technology
Concept
Tumor Therapeutic Products Lymphoma
Application Scenarios
Biologics Innovative Drugs